Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105468
Filing Date
2025-08-08
Accepted
2025-08-08 07:15:49
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20250630.htm   iXBRL 10-Q 2764576
2 EX-10.1 rptx-ex10_1.htm EX-10.1 164911
3 EX-10.2 rptx-ex10_2.htm EX-10.2 70281
4 EX-31.1 rptx-ex31_1.htm EX-31.1 17136
5 EX-32.1 rptx-ex32_1.htm EX-32.1 9841
6 GRAPHIC img46999202_0.jpg GRAPHIC 16694
7 GRAPHIC img195065743_0.jpg GRAPHIC 49567
  Complete submission text file 0000950170-25-105468.txt   11363569

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20250630.xsd EX-101.SCH 1204542
80 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20250630_htm.xml XML 2429050
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 251196191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)